UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, ~~D.C.~~DC 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):

~~December~~May 3022, ~~2024~~2025

ALEXANDERS INC

(Exact Name of Registrant as Specified in Charter)

Delaware

001-06064

51-0100517

(State or Other

(Commission

(IRS Employer

Jurisdiction of Incorporation)

File Number)

Identification No.)

210 Route 4 East

Paramus,

New Jersey

07652

(Address of Principal Executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (201) 587-8541

Former name or former address, if changed since last report: N/A

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2.):


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $1 par value per share

ALX

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 5.0207. ~~Departure~~Submission of ~~Directors~~Matters orto ~~Certain~~a ~~Officers;~~Vote ~~Election~~ of ~~Directors;~~Security ~~Appointment of Certain Officers; Compensatory~~Holders.

On ~~December~~May 3022, ~~2024~~2025, ~~due to health reasons~~Alexander’s, DrInc. ~~Richard~~(the ~~West~~“Company”) ~~submitted~~held ~~his~~its ~~resignation~~2025 ~~from~~Annual ~~the~~Meeting ~~Board~~ of ~~Directors~~Stockholders (the “~~Board~~Meeting”). As of ~~Alexander’s~~March 24, ~~Inc.~~2025, (the ~~“Company”),~~record ~~including~~date ~~from~~for ~~his~~stockholders ~~role~~entitled asto ~~Chair~~vote ofat the ~~Audit~~Meeting, ~~Committee~~there were 5,107,290 shares of ~~the~~common ~~Board~~stock, par value $1.00 per share (the “~~Audit Committee~~Shares”) outstanding and ~~Chair~~entitled ofto vote. Of the ~~Compensation~~Shares ~~Committee~~entitled (to vote at the ~~“Compensation~~Meeting, ~~Committee”)~~4,845,508, ~~effective~~or asapproximately 94.87% of ~~January~~the 1Shares, ~~2025~~were present or represented by proxy. There were two matters presented and voted on. Set forth below is a brief description of each matter voted on and the voting results with respect to each such matter.

~~Effective~~Proposal ~~January~~ 1, ~~2025,~~– ~~the~~Election ~~Board reduced the size~~ of ~~the~~two ~~Board~~nominees to ~~seven~~serve ~~(7)~~on ~~directors,~~the ~~eliminated~~Board ~~its~~of ~~Executive~~Directors ~~Committee~~for ~~and~~a ~~appointed~~three-year ~~Mandakini~~term ~~Puri as Chair of the Audit Committee~~ and ~~Wendy~~until A.their ~~Silverstein~~respective assuccessors ~~Chair~~are ofduly ~~the Compensation Committee~~elected.

Dr. West’s decision to resign was not the result of any disagreement with management or the Board, on any matter relating to the Company’s operations, policies, or practices.


Nominee	For	Withheld	Broker Non-Votes

Steven Roth	4,340,326	229,755	275,427
Wendy A. Silverstein	4,419,673	150,408	275,427

~~The~~Proposal ~~Company~~2 is– ~~very~~Ratification ~~grateful~~of ~~for~~Deloitte ~~Dr.~~& ~~West’s~~Touche ~~extraordinary~~LLP ~~dedication~~as ~~over~~ the ~~course~~Company’s ofindependent ~~his~~registered ~~many~~public ~~years~~accounting offirm ~~service~~for on the ~~Board~~fiscal year 2025.


	For	Against	Abstain

Votes Cast	4,839,960	4,717	831

In addition to the two nominees who were re-elected to serve on the Company’s Board of Directors, Thomas R. DiBenedetto, David M. Mandelbaum, Mandakini Puri, Arthur I. Sonnenblick and Russell B. Wright, Jr. continue to serve as Directors after the Meeting.

Item 9.01. Financial Statements and Exhibits.

Exhibit No.

Description

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



ALEXANDER’S, INC.
(Registrant)

	By:	/s/ Gary Hansen
	Name:	Gary Hansen
	Title:	Chief Financial Officer (duly authorized officer and principal financial and accounting officer)

Date: ~~December~~May 3022, ~~2024~~ 2025

Filing Compare · ALEXANDERS INC